机器学习在应用小分子药性预测预测方面的进展
Junyao Li1, Jianmei Zhang2, Rui Guo3
1School of Chemistry and Life Sciences, Suzhou University of Science and Technology, Suzhou, China; School of Life Sciences, Huaiyin Normal University, Huaian, 223300, China; Institute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou, 225009, China.
European journal of medicinal chemistry
|January 14, 2025
概括
机器学习 (ML) 模型快速预测小分子的药物特性,加速药物发现. 机器学习有助于虚拟选和数据生成,克服复合和目标数据的局限性.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 生物信息学是一种生物信息学.
背景情况:
- 机器学习 (ML) 对于预测小分子的药物特性至关重要.
- ML算法可以快速准确地评估溶解性,活性,毒性和药理动力学.
- ML模型通过虚拟查和对药物向相互作用的分析加速了化合物查.
研究的目的:
- 提供ML应用在预测小分子制药性质方面的简要概述.
- 讨论用于药物发现的ML中的模型构建原理和分子特征选择.
- 探索ML在选制药小分子中的潜力.
主要方法:
- 对 ML 算法用于分子性质预测的最新进展的审查.
- 分析ML模型构建原理和分子特征选择技术.
- 讨论ML在虚拟查和药物向相互作用阐明中的应用.
主要成果:
- ML可以准确预测各种药物特性 (溶解性,活性,毒性,药理动力学).
- 机器学习促进了大型化合物库的虚拟选,加速了化合物识别.
- 通过利用现有的实验数据进行培训和生成新的数据集,ML解决了数据稀缺问题.
结论:
- 机器学习是加速制药研发的强大工具.
- 在预测小分子特性方面的ML应用正在扩大,对药物发现有很大的潜力.
- 进一步开发和应用ML将提高识别新药候选药物的效率和准确性.
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Protein-Drug Binding: Determination Methods
117
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
117


